This brand name is authorized in Brazil
The drug XANTINON COMPLEX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Methionine
UNII 383941IGXN - N-ACETYLMETHIONINE, DL-
|
|
|
|
2
Betaine
UNII 3SCV180C9W - BETAINE
|
|
Betaine anhydrous was shown to lower plasma homocysteine levels in the three types of homocystinuria, i.e. CBS deficiency; MTHFR deficiency and cbl defect. The extent of this effect was dependent on the absolute degree of hyperhomocysteinemia, being higher in severe hyperhomocysteinemia. Betaine anhydrous acts as a methyl group donor in the remethylation of homocysteine to methionine in patients with homocystinuria. |
|
3
Choline citrate
UNII EH8N140TJ7 - TRICHOLINE CITRATE
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501103305130417, 501103401131410, 501103402136416, 501118120029503, 501118120029603, 501120120032007 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
